Tuesday, April 09, 2019 6:02:00 PM
In attendance will be our Chief Research Officer from Australia, Dr. Harry Parekh and our Chief Science Officer & President, Dr. Mak Jawadekar from East Lyme, CT; as well as our CEO and Chairman Stephen Van Deventer and the rest of the PreveCeutical team.
Come by and meet the team!
Please RSVP by April 24th, 2019, using the link below.
https://www.eventbrite.ca/e/preveceutical-medical-inc-open-house-tickets-59793768772
Event Details
Date: April 26th, 2019, 12:00PM to 4:00PM
Location: PreveCeutical Medical Inc.
Suite 2200 – 1177 West Hastings Street, Vancouver, BC
On Behalf of the Board,
Stephen Van Deventer
Chairman & CEO
PreveCeutical Medical Inc.
Recent PRVCF News
- Dual Listed Biotech Begins to Prepare POC Preclinical Study for Diabetes & Obesity Dual Gene Therapy Program • AllPennyStocks.com • 12/04/2023 01:00:00 PM
- Dual Listed Biotech Begins to Prepare POC Preclinical Study for Diabetes & Obesity Dual Gene Therapy Program • AllPennyStocks.com • 12/04/2023 01:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM